CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-30 | Bowden Christopher Chief Medical Officer | Sale | −1,700 | $80.03 | $136K | 924 |
| 2018-08-30 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −1,700 | 91,000 | ||
| 2018-08-29 | Bowden Christopher Chief Medical Officer | Option exercise | +300 | $35.16 | $11K | 1,224 |
| 2018-08-29 | Bowden Christopher Chief Medical Officer | Sale | −300 | $80.00 | $24K | 924 |
| 2018-08-29 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −300 | 92,700 | ||
| 2018-08-24 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +2,050 | $39.76 | $82K | 2,050 |
| 2018-08-24 | Hoerter Steven L. Chief Commercial Officer | Sale | −2,050 | $74.92 | $154K | 0 |
| 2018-08-24 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −2,050 | 60,650 | ||
| 2018-08-06 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 60,196 |
| 2018-08-06 | Biller Scott Chief Scientific Officer | Sale | −300 | $78.32 | $23K | 59,896 |
| 2018-08-06 | Biller Scott Chief Scientific Officer | Sale | −2,100 | $80.15 | $168K | 57,796 |
| 2018-08-06 | Biller Scott Chief Scientific Officer | Sale | −600 | $80.87 | $49K | 57,196 |
| 2018-08-06 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −3,000 | 13,154 | ||
| 2018-07-25 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +2,050 | $39.76 | $82K | 2,050 |
| 2018-07-25 | Hoerter Steven L. Chief Commercial Officer | Sale | −2,050 | $84.58 | $173K | 0 |
| 2018-07-25 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −2,050 | 62,700 | ||
| 2018-07-20 | Hoerter Steven L. Chief Commercial Officer | Grant or award · Performance share units | +15,000 | 15,000 | ||
| 2018-07-20 | Hirsch Andrew Chief Financial Officer | Grant or award · Performance share units | +15,000 | 15,000 | ||
| 2018-07-20 | Bowden Christopher Chief Medical Officer | Grant or award · Performance share units | +6,265 | 6,265 | ||
| 2018-07-10 | Bowden Christopher Chief Medical Officer | Option exercise | +2,000 | $35.16 | $70K | 2,924 |
Page 58 of 63 · 1,252 trades